(Q24324162)

GOA release 2020-03-11

tumor protein p53

1 reference

positive regulation of peptidyl-serine dephosphorylation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

X Shang

1

0 references

S A Vasudevan

2

0 references

Y Yu

3

0 references

N Ge

4

0 references

A D Ludwig

5

0 references

C L Wesson

6

0 references

K Wang

7

0 references

S M Burlingame

8

0 references

Y-J Zhao

9

0 references

P H Rao

10

0 references

X Lu

11

0 references

H V Russell

12

0 references

M F Okcu

13

0 references

M J Hicks

14

0 references

J M Shohet

15

0 references

L A Donehower

16

0 references

J G Nuchtern

17

0 references

J Yang

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer

18

0 references

language of work or name

English

0 references

publication date

2 September 2010

0 references

published in

Oncogene

0 references

volume

29

0 references

page(s)

4938-46

0 references

issue

35

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Dual-specificity phosphatases: critical regulators with diverse cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Neuroblastoma: biological insights into a clinical enigma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

p53 and MDM2: antagonists or partners in crime?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Strategies for manipulating the p53 pathway in the treatment of human cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

31 March 2020

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

p53, the cellular gatekeeper for growth and division

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

p53 status and the efficacy of cancer therapy in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Small molecule inhibitors of dual specificity protein phosphatases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

The p53 pathway and its inactivation in neuroblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

MKP-8, a novel MAPK phosphatase that inhibits p38 kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

31 March 2020

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Live or let die: the cell's response to p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.244

Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20562916

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20562916

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The residues of Ras and Rap proteins that determine their GAP specificities.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20562916